June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's type 1 ...
The FDA has approved capivasertib (Truqap) in combination with abiraterone acetate (Zytiga) and prednisone for adults with ...
Sanofi secured accelerated approval from the Food and Drug Administration for its drug Tzield to be used in the treatment of people with the autoimmune and progressive nature of stage 3 type 1 ...
The action comes as federal and state officials respond to the outbreak of the flesh-eating parasite.
Bemotrizinol is a powerful, broad-spectrum blocker of dangerous rays that has been used in Europe for years.
FDA Approves KEYTRUDA® and KEYTRUDA QLEXTM , Each With WELIREG®, for Adjuvant Treatment of Certain Patients With ccRCC ...
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher Capricor Therapeutics (NASDAQ:CAPR) executives said the company ...
New FDA-approved sunscreen options could expand sun protection choices in the United States. Experts examine their potential ...